Found 5 matching trials
Study of MCLA-129 in the Treatment of Advanced Non-small Cell Lung Cancer with AGA and MET Amplification. PHASE2 This is a multi-center, open-label, phase II clinical study of MCLA-129 as ...
Show More Location
The First Affiliated Hospital of Anhui Medical University
Learn More & Join Trial
Study of MCLA-129 Combined With Befotertinib in the Treatment of Advanced Non-small Cell Lung Cancer With EGFR Sensitive Mutation PHASE1 To evaluate the safety and tolerance of MCLA-129 combined with Befotertinib...
Show More Location
The first affiliated hospital of bengbu medical college
Learn More & Join Trial
Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination PHASE1 A phase 1/2 open-label multicenter study will be performed with an initial ...
Show More Status
Active Not Recruiting
Location
University of California, Irvine
Learn More & Join Trial
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors PHASE1 This is a multi-center, open-label, Phase I/II clinical study of MCLA-129 a...
Show More Location
Affiliated Hospital of Hebei University
Learn More & Join Trial
Study of MCLA-129 in Combination With Ensartinib in Patients With Advanced Solid Tumors. PHASE1 This is a multicenter, open-label Phase I/II clinical study to evaluate the...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial